131 related articles for article (PubMed ID: 2239452)
1. Neurotrophic factors and Parkinson's disease.
Hefti F; Michel PP; Knusel B
Adv Neurol; 1990; 53():123-7. PubMed ID: 2239452
[No Abstract] [Full Text] [Related]
2. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
[TBL] [Abstract][Full Text] [Related]
3. [Nerve regeneration].
Liesi P
Duodecim; 1990; 106(10):798-807. PubMed ID: 1670295
[No Abstract] [Full Text] [Related]
4. Parkinson's disease: a neurodegenerative disease particularly amenable to gene therapy.
Bohn MC
Mol Ther; 2000 Jun; 1(6):494-6. PubMed ID: 10933972
[No Abstract] [Full Text] [Related]
5. Neurotrophic factors and Parkinson's disease: the emergence of a new player?
Dauer W
Sci STKE; 2007 Nov; 2007(411):pe60. PubMed ID: 17986711
[TBL] [Abstract][Full Text] [Related]
6. Embryonic dopamine cell implants as a treatment for the second phase of Parkinson's disease. Replacing failed nerve terminals.
Freed CR; Breeze RE; Rosenberg NL; Schneck SA
Adv Neurol; 1993; 60():721-8. PubMed ID: 8420217
[No Abstract] [Full Text] [Related]
7. Brain neurotransmitters and neuropeptides in Parkinson's disease.
Rinne UK; Rinne JO; Rinne JK; Laakso K; Lönnberg P
Acta Physiol Pharmacol Latinoam; 1984; 34(3):287-99. PubMed ID: 6099688
[TBL] [Abstract][Full Text] [Related]
8. Are dopaminergic neurons selectively vulnerable to Parkinson's disease?
Agid Y; Ruberg M; Javoy-Agid F; Hirsch E; Raisman-Vozari R; Vyas S; Faucheux B; Michel P; Kastner A; Blanchard V
Adv Neurol; 1993; 60():148-64. PubMed ID: 8420132
[No Abstract] [Full Text] [Related]
9. Neurotrophins in the pathogenesis and potential treatment of Parkinson's disease.
Bradford HF; Zhou J; Pliego-Rivero B; Stern GM; Jauniaux E
Adv Neurol; 1999; 80():19-25. PubMed ID: 10410698
[No Abstract] [Full Text] [Related]
10. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease.
Appel SH
Ann Neurol; 1981 Dec; 10(6):499-505. PubMed ID: 6173010
[TBL] [Abstract][Full Text] [Related]
11. [Neurotrophic factor and the processes of reparative regeneration].
Pavlov VA; Rodionov SIu
Vestn Akad Med Nauk SSSR; 1990; (8):60-3. PubMed ID: 2275281
[No Abstract] [Full Text] [Related]
12. Parkinson's disease. Fresh factors to consider.
Snyder SH
Nature; 1991 Mar; 350(6315):195. PubMed ID: 2005976
[No Abstract] [Full Text] [Related]
13. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease.
Björklund A; Rosenblad C; Winkler C; Kirik D
Neurobiol Dis; 1997; 4(3-4):186-200. PubMed ID: 9361295
[TBL] [Abstract][Full Text] [Related]
14. [Surgical therapy for Parkinson's disease].
Tomita S; Date I; Ohmoto T
No To Shinkei; 2000 Nov; 52(11):947-58. PubMed ID: 11215268
[No Abstract] [Full Text] [Related]
15. [Recent progress in development of psychotropic drugs (3)--Antiparkinsonian agents applied in the treatment of Parkinson's disease or are under investigation for patients or model animals].
Nomoto M
Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Aug; 16(4):113-22. PubMed ID: 8905800
[TBL] [Abstract][Full Text] [Related]
16. Glial cell line-derived neurotrophic factor: a novel therapeutic approach to treat motor dysfunction in Parkinson's disease.
Lapchak PA; Gash DM; Jiao S; Miller PJ; Hilt D
Exp Neurol; 1997 Mar; 144(1):29-34. PubMed ID: 9126148
[TBL] [Abstract][Full Text] [Related]
17. Potential of gene therapy for Parkinson's disease: neurobiologic issues and new developments in gene transfer methodologies.
Kang UJ
Mov Disord; 1998; 13 Suppl 1():59-72. PubMed ID: 9613721
[TBL] [Abstract][Full Text] [Related]
18. Dopamine and Parkinson's disease: is the killer in the house?
Chesselet MF
Mol Psychiatry; 2003 Apr; 8(4):369-70. PubMed ID: 12740592
[No Abstract] [Full Text] [Related]
19. The role of target tissues in development and regeneration-retrophins.
Hendry IA; Bonyhady RE; Hill CE
Birth Defects Orig Artic Ser; 1983; 19(4):263-76. PubMed ID: 6871397
[No Abstract] [Full Text] [Related]
20. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms.
Hornykiewicz O
Adv Neurol; 1993; 60():140-7. PubMed ID: 8420131
[No Abstract] [Full Text] [Related]
[Next] [New Search]
